美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

知臨集團

5.71

-0.5200-8.35%

盤後：5.870.1615+2.83%19:43 EDT

成交量：3.71萬

成交額：22.17萬

市值：465.01萬

市盈率：-2.00

高：6.20

開：6.08

低：5.68

收：6.23

52周最高：25.90

52周最低：5.68

股本：81.44萬

流通股本：52.99萬

量比：0.04

換手率：7.00%

股息：- -

股息率：- -

每股收益(TTM):-2.8593

每股收益(LYR):-1.8543

淨資產收益率：-17.05%

總資產收益率：-10.04%

市淨率：0.21

市盈率(LYR):-3.08

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

知臨集團

交易所：

NASDAQ

成立時間：

2010

員工人數：

- -

公司地址：

116 Village Boulevard,Suite 200,Princeton,New Jersey,United States

官網：

http://www.aptorumgroup.com

郵編：

08540

電話：

傳真：

- -

簡介：

Niki BioSolutions, Inc.於2010年9月13日根據開曼群島法律註冊成立，並於2026年7月20日在特拉華州重新註冊成立。該公司通過其全資子公司和間接子公司從事生命科學和生物製藥產品的研發。其子公司DiamiR Biosciences Corp.是一家分子診斷公司，專註於開發用於早期檢測和監測輕度認知障礙、阿爾茨海默病、帕金森病、其他神經退行性疾病和癌症的非侵入性檢測方法。該公司的專有技術基於對血漿中循環器官富集的miRNA進行定量分析。該公司的短期目標包括根據已識別的miRNA特徵，在CLIA指南下開發實驗室自建檢測方法，這些方法將用於篩查、患者分層以及疾病和治療監測。

董事

名稱

職位

Ian Huen

Chairman and Chief Executive Officer and Director

Douglas Arner

Independent Non-Executive Director

Justin Wu

Independent Non-Executive Director

Kira Sheinerman

Executive Director and Secretary and Treasurer

Laura A. Philips

Independent Non-Executive Director

股東

名稱

職位

Ian Huen

Chairman and Chief Executive Officer and Director

Gary Anthony

Chief Financial Officer

Alidad Mireskandari

Chief Operation Officer and President

Kira Sheinerman

Executive Director and Secretary and Treasurer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/NIKI/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NIKI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NIKI\",,,,,undefined,":{"symbol":"NIKI","market":"US","secType":"STK","nameCN":"知臨集團","latestPrice":5.71,"timestamp":1789156800000,"preClose":6.23,"halted":0,"volume":37082,"hourTrading":{"tag":"盘后","latestPrice":5.8715,"preClose":5.71,"latestTime":"19:43 EDT","volume":1698,"amount":9818.4843,"timestamp":1789170211092,"change":0.1615,"changeRate":0.028284,"amplitude":0.045534},"delay":0,"changeRate":-0.08346709470304983,"floatShares":529900,"shares":814380,"eps":-2.859312,"marketStatus":"休市中","change":-0.52,"latestTime":"09-11 16:00:00 EDT","open":6.08,"high":6.2,"low":5.68,"amount":221669.057715,"amplitude":0.083467,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.859312,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1545195600000,"exchange":"NASDAQ","adjPreClose":6.23,"preHourTrading":{"tag":"盘前","latestPrice":6.08,"preClose":6.23,"latestTime":"09:21 EDT","volume":1825,"amount":11219.50432,"timestamp":1789132914721,"change":-0.15,"changeRate":-0.024077,"amplitude":0.05939},"postHourTrading":{"tag":"盘后","latestPrice":5.8715,"preClose":5.71,"latestTime":"19:43 EDT","volume":1698,"amount":9818.4843,"timestamp":1789170211092,"change":0.1615,"changeRate":0.028284,"amplitude":0.045534},"volumeRatio":0.04278906911775616},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NIKI\",,,,,undefined,":{"symbol":"NIKI","floatShares":529900,"roa":"-10.04%","roe":"-17.05%","lyrEps":-1.85433,"volumeRatio":0.04278906911775616,"shares":814380,"dividePrice":0,"high":6.2,"amplitude":0.083467,"preClose":6.23,"low":5.68,"week52Low":5.68,"pbRate":"0.21","week52High":25.899,"institutionHeld":0,"latestPrice":5.71,"eps":-2.859312,"divideRate":0,"volume":37082,"delay":0,"ttmEps":-2.859312,"open":6.08,"prevYearClose":10.6,"prevWeekClose":6.2,"prevMonthClose":6.86,"prevQuarterClose":7.822,"fiveDayClose":6.51,"twentyDayClose":8.37,"sixtyDayClose":8.426},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NIKI\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NIKI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NIKI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NIKI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NIKI","date":"2026-09-11","current":-1.996984,"percent":0.314286,"low":-11.218451,"twenty":-8.655859,"median":-5.719806,"eighty":-5.238924,"high":-4.772977,"avg":-6.845017,"sd":1.974449,"marketCap":18307633},"quantilePoints":[{"date":"2026-07-24","current":-5.125424,"twenty":-5.501767,"median":-5.322556,"eighty":-5.21503,"marketCap":6987337},{"date":"2026-07-31","current":-6.07524,"twenty":-5.567477,"median":-5.304635,"eighty":-5.170824,"marketCap":8282193},{"date":"2026-08-07","current":-5.549556,"twenty":-5.763414,"median":-5.549556,"eighty":-5.253261,"marketCap":7565543},{"date":"2026-08-14","current":-4.999977,"twenty":-5.720403,"median":-5.370346,"eighty":-5.185161,"marketCap":6816318},{"date":"2026-08-20","current":-4.868556,"twenty":-5.713235,"median":-5.349438,"eighty":-5.044182,"marketCap":6637156},{"date":"2026-08-28","current":-9.858639,"twenty":-6.039398,"median":-5.370346,"eighty":-5.130203,"marketCap":22157232},{"date":"2026-09-04","current":-8.511902,"twenty":-8.906797,"median":-5.654096,"eighty":-5.16724,"marketCap":19130448},{"date":"2026-09-11","current":-8.145798,"twenty":-8.655859,"median":-5.719806,"eighty":-5.238924,"marketCap":18307633}],"updateTime":1789232720752},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":254483578,"yearFounded":2010,"address":"116 Village Boulevard,Suite 200,Princeton,New Jersey,United States","zipCode":"08540","officePhone":"609 951 2222","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.aptorumgroup.com","stockEarnings":[{"period":"1week","weight":-0.079},{"period":"1month","weight":-0.404},{"period":"3month","weight":-0.3344},{"period":"6month","weight":-0.279},{"period":"1year","weight":-0.6914},{"period":"ytd","weight":-0.4613}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Niki BioSolutions, Inc.於2010年9月13日根據開曼群島法律註冊成立，並於2026年7月20日在特拉華州重新註冊成立。該公司通過其全資子公司和間接子公司從事生命科學和生物製藥產品的研發。其子公司DiamiR Biosciences Corp.是一家分子診斷公司，專註於開發用於早期檢測和監測輕度認知障礙、阿爾茨海默病、帕金森病、其他神經退行性疾病和癌症的非侵入性檢測方法。該公司的專有技術基於對血漿中循環器官富集的miRNA進行定量分析。該公司的短期目標包括根據已識別的miRNA特徵，在CLIA指南下開發實驗室自建檢測方法，這些方法將用於篩查、患者分層以及疾病和治療監測。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.088822},{"month":2,"riseRate":0,"avgChangeRate":-0.194854},{"month":3,"riseRate":0.375,"avgChangeRate":0.51635},{"month":4,"riseRate":0.375,"avgChangeRate":-0.096135},{"month":5,"riseRate":0.625,"avgChangeRate":0.215152},{"month":6,"riseRate":0.375,"avgChangeRate":-0.032154},{"month":7,"riseRate":0.375,"avgChangeRate":0.022127},{"month":8,"riseRate":0.5,"avgChangeRate":-0.081585},{"month":9,"riseRate":0.5,"avgChangeRate":-0.057024},{"month":10,"riseRate":0,"avgChangeRate":-0.214094},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.103938},{"month":12,"riseRate":0.428571,"avgChangeRate":0.469465}],"exchange":"NASDAQ","name":"知臨集團","nameEN":"Aptorum Group Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NIKI\",market:\"US\",,,undefined,":{"directors":[{"name":"Ian Huen","position":"Chairman and Chief Executive Officer and Director"},{"name":"Douglas Arner","position":"Independent Non-Executive Director"},{"name":"Justin Wu","position":"Independent Non-Executive Director"},{"name":"Kira Sheinerman","position":"Executive Director and Secretary and Treasurer"},{"name":"Laura A. Philips","position":"Independent Non-Executive Director"}],"executives":[{"name":"Ian Huen","position":"Chairman and Chief Executive Officer and Director"},{"name":"Gary Anthony","position":"Chief Financial Officer"},{"name":"Alidad Mireskandari","position":"Chief Operation Officer and President"},{"name":"Kira Sheinerman","position":"Executive Director and Secretary and Treasurer"}]}}}